AQST
Aquestive Therapeutics Inc
4.60$
+0.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +77.6% | -55.7% | -1.0% | -22.4% | -7.5% | -5.4% | +0.7% | -0.7% | -6.5% | -13.1% | +20.4% | – | |
| – | +21.4% | +68.1% | -2.6% | +2.5% | +52.4% | -34.0% | +18.7% | +47.4% | -50.5% | +68.5% | +24.9% | – | |
| – | – | – | – | – | – | -194.5% | – | -413.2% | – | -164.7% | – | – | |
| – | -89.4% | +81.3% | +20.7% | +128.6% | -81.3% | +800.0% | -20.7% | +119.6% | -63.8% | -38.8% | +307.7% | – | |
| – | -89.4% | +81.3% | +20.7% | +128.6% | -81.3% | +800.0% | -20.7% | +119.6% | -63.8% | -38.8% | +307.7% | – | |
| – | – | -8,218.2% | -99.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -37.5% | +20.0% | +33.3% | -12.5% | -28.6% | +60.0% | – | – | |
| – | -21.4% | +1,989.0% | -97.9% | -101.0% | – | +13,050.3% | -100.5% | – | -99.2% | +570.2% | -158.6% | – | |
| – | -142.1% | – | -107.5% | – | – | – | – | – | -111.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.